Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP Pharmaceuticals to make new filing for approval of inhaled migraine drug later in 2012
MAP Pharmaceuticals to make new filing for approval of inhaled migraine drug later in 2012
MAP Pharmaceuticals to make new filing for approval of inhaled migraine drug later in 2012
Submitted by
admin
on June 25, 2012 - 11:44am
Source:
Yahoo/AP
News Tags:
MAP Pharmaceuticals
migraines
Levadex
Headline:
MAP Pharmaceuticals to make new filing for approval of inhaled migraine drug later in 2012
Do Not Allow Advertisers to Use My Personal information
